341
Views
5
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Glucose-6-phosphate dehydrogenase deficiency and risk of invasive fungal disease in patients with acute myeloid leukemia

, , , , , , , & show all
Pages 2558-2564 | Received 05 Feb 2017, Accepted 20 Mar 2017, Published online: 12 Apr 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (4)

Pinki Mishra, Narendra Agrawal, Dinesh Bhurani & Nidhi Bharal Agarwal. (2019) Invasive Fungal Infections in Patients with Acute Myeloid Leukemia Undergoing Intensive Chemotherapy. Indian Journal of Hematology and Blood Transfusion 36:1, pages 64-70.
Crossref
Stephanie M. Lauden, Stella Chongwain, Anzeh Achidi, Ethan Helm, Sarah E. Cusick, Amelia Krug, Tina M. Slusher & Troy C. Lund. (2019) Prevalence of glucose-6-phosphate dehydrogenase deficiency in Cameroonian blood donors. BMC Research Notes 12:1.
Crossref
Shahrzad Zamani, Ahmad Zavaran Hoseini & Alireza Mesbah Namin. (2019) Glucose-6-phosphate dehydrogenase (G6PD) activity can modulate macrophage response to Leishmania major infection. International Immunopharmacology 69, pages 178-183.
Crossref
Abdel B. Halim. 2019. Biomarkers, Diagnostics and Precision Medicine in the Drug Industry. Biomarkers, Diagnostics and Precision Medicine in the Drug Industry 11 40 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.